Identification of a Novel Mutation Combination in Factor XIII Deficiency: Genetic Update to the First Reported Case in the United States

被引:0
|
作者
Amy Halverstadt
Sean Walsh
Stephen M. Roth
Robert E. Ferrell
James M. Hagberg
机构
[1] University of Maryland,Department of Kinesiology
[2] University of Pittsburgh Graduate School of Public Health,Department of Human Genetics
来源
关键词
FXIII; Splicing mutation; Missense mutation; Genetics; Genetic disease;
D O I
暂无
中图分类号
学科分类号
摘要
A 1967 report described the first known case of congenital factor XIII (FXIII) deficiency in the United States in a male patient with a severe hemorrhagic disorder.The patient’s family presented no symptoms of the disorder, but the members were found to have half the normal FXIII activity. Although the molecular basis of the disorder could not be evaluated at the time, the results suggested an autosomal recessive inherited disorder.We sequenced all of the exons and the flanking regions in the genes for the FXIII A and B subunits of the patient, his family, and 18 unrelated individuals.We report the novel combination of an Arg-to-Cys mutation at codon 78 and a G-to-C mutation at the intron 5/exon 6 splice junction in the patient’s FXIIIA gene.The missense-splice junction mutation combination appears to have caused the patient’s FXIIIA deficiency, because the remaining family members, who present no symptoms and have no clinical diagnoses of FXIII deficiency, have one or the other of the 2 mutations but not both. Additionally, the 18 unrelated individuals are homozygous wild type at these loci.The molecular consequences of these mutations appear to be an abnormality in protein conformation or folding and/or a reduced production of messenger RNA transcripts of varying length that likely result in a nonfunctional, unstable FXIII protein.
引用
收藏
页码:144 / 146
页数:2
相关论文
共 50 条
  • [31] Molecular mechanisms of type II factor XIII deficiency: Novel Gly562-Arg mutation and C-terminal truncation of the a subunit cause factor XIII deficiency as characterized in a Mammalian expression system
    Takahashi, N
    Tsukamoto, H
    Umeyama, H
    Castaman, G
    Rodeghiero, F
    Ichinose, A
    BLOOD, 1998, 91 (08) : 2830 - 2838
  • [32] The first reported case of factor V Leiden mutation with agenesis of superior vena cava: A case report
    De Souza, Valter Romao, Jr.
    Valenca de Lemos, Victor Moreira
    Araujo Lafayette, Daniell de Siqueira
    de Lemos, Roberto Souza
    Correia Fontes, Luciana de Barros
    Torres de Lima, Glaydes Maria
    de Barros Correia, Claudia Wanderley
    Coutinho Domingues, Ana Lucia
    da Mota Silveira Aroucha, Amanda Queiroz
    de Oliveira, Igor Macedo
    Santos, Gabriel Pinheiro
    Vanderlei, Ana Maria
    Valenca de Lemos, Vladmyr Moreira
    Sostenes Peter, Joao Vitor
    Vieira, Juliana Oliveira
    Pereira Mariano, Aline Rayane
    Gomes, Turibio Anacleto
    de Souza Ferraz, Alice Marcelle
    Sousa do Amaral, Jose Henrique
    Lins, Esdras Marques
    Cavalcanti Bezerra, Marcos Andre
    Ramos de Araujo, Paulo Sergio
    de Vasconcelos, Adriana Ferraz
    de Barros Correia, Maria da Conceicao
    Hazin Costa, Manuela Freire
    MEDICINE, 2018, 97 (22)
  • [33] A novel compound heterozygous mutation in the F13A gene causing hereditary factor XIII deficiency in a Chinese family
    Wu, S
    Wang, Z
    Dong, N
    Bai, X
    Ruan, C
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 267 - 269
  • [34] Partial HPRT Deficiency with a Novel Mutation of the HPRT Gene in Combination with Four Previously Reported Variants Associated with Hyperuricemia
    Kurajoh, Masafumi
    Koyama, Hidenori
    Hatayama, Miki
    Okazaki, Hirokazu
    Shoji, Takuhito
    Moriwaki, Yuji
    Yamamoto, Tetsuya
    Nakayama, Tomitaka
    Namba, Mitsuyoshi
    INTERNAL MEDICINE, 2015, 54 (12) : 1523 - 1526
  • [35] Congenital factor XIII deficiency in Switzerland - From the worldwide first case in 1960 to its molecular characterisation in 2005
    Schroeder, Verena
    Durrer, Dominik
    Meili, Esther
    Schubiger, Gregor
    Kohler, Hans Peter
    SWISS MEDICAL WEEKLY, 2007, 137 (19-20) : 272 - 278
  • [36] Molecular mechanisms of Type II factor XIII deficiency: Novel Gly562-Arg mutation and C-terminal truncation of the a subunit cause factor XIII deficiency as characterized in a mammalian expression system.
    Takahashi, N
    Tsukamoto, H
    Umeyama, H
    Castaman, G
    Rodeghiero, F
    Yamazaki, T
    Ichinose, A
    BLOOD, 1997, 90 (10) : 2062 - 2062
  • [37] Molecular genetic analysis of factor XI deficiency: Identification of five novel gene alterations and the origin of type II mutation in Portuguese families
    Ventura, C
    Santos, AIM
    Tavares, A
    Gago, T
    Lavinha, J
    McVey, JH
    David, D
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) : 833 - 840
  • [38] First description of phosphofructokinase deficiency in spain: identification of a novel homozygous missense mutation in the PFKM gene
    Vives-Corrons, Joan-Lluis
    Koralkova, Pavla
    Grau, Josep M.
    Manu Pereira, Maria del Mar
    Van Wijk, Richard
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [39] A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency
    Xie, Haixiao
    Wang, Mingshan
    Jin, Yanhui
    Li, Xiaolong
    Jiang, Shuting
    Yang, Lihong
    BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (06) : 337 - 341
  • [40] Cavitary Lesions Of Lungs: First Reported Case Of Mycobacterium Shimoidei Infection In The United States Of America
    Trivedi, K.
    Patel, P. M.
    Tindel, S.
    Payne, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193